1700063H04Rik Inhibitors represent a specialized group of compounds that interact with the protein encoded by the 1700063H04Rik gene. This particular class of chemicals is characterized by their unique ability to modulate the function of the 1700063H04Rik protein, a molecule that plays a role in specific cellular pathways and processes. The inhibitors typically achieve this modulation by binding to the protein, thereby altering its structural conformation, or by interfering with its ability to interact with other cellular components. These interactions can lead to changes in the protein's activity, potentially altering the pathways in which it is involved. The development of these inhibitors is driven by a deep interest in the underlying biochemistry of the 1700063H04Rik protein, including its role in cellular function and the regulation of various biological processes. The inhibitors themselves are diverse in their chemical structure, reflecting the complex nature of protein-inhibitor interactions. This diversity is a product of extensive research and experimentation aimed at understanding the specific binding sites and interaction mechanisms of the 1700063H04Rik protein. As a result, the inhibitors can vary significantly in their size, polarity, and functional groups, tailored to interact effectively with the protein's unique structure.
The study and application of 1700063H04Rik Inhibitors are primarily focused on elucidating the biological role of the 1700063H04Rik protein. By inhibiting this protein, researchers can observe changes in cellular behavior, providing insights into the protein's function. This can include understanding how the protein interacts with other cellular components, its role in signal transduction pathways, or its involvement in the regulation of gene expression. The inhibitors are valuable tools in experimental biology, allowing scientists to probe the intricacies of cellular mechanisms at a molecular level. They also contribute to the broader field of biochemistry, where understanding protein function and interactions is crucial.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), which is shown to affect signal transduction pathways involving protein kinase B (AKT), potentially impacting proteins like 1700063H04Rik if it's part of the PI3K/AKT pathway. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
An inhibitor of histone deacetylases (HDACs), affecting gene expression. If 1700063H04Rik is regulated by acetylation, Trichostatin A is shown to influence its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A inhibitor of PI3K, similar to Wortmannin, which is shown to affect proteins involved in the PI3K/AKT signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, affecting cellular growth and metabolism. If 1700063H04Rik is part of mTOR-related pathways, Rapamycin is shown to indirectly modulate its activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad-spectrum inhibitor of protein kinases, which could impact a wide range of proteins involved in cellular signaling, potentially including 1700063H04Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
An inhibitor of p38 MAP kinase, involved in response to stress and inflammation. Which is shown to influence proteins linked to these pathways, including potentially 1700063H04Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A specific inhibitor of MEK, which blocks the MAPK/ERK pathway. This could indirectly affect proteins associated with this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), part of the MAPK pathway, which is shown to impact proteins involved in stress and apoptosis signaling. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
A glycolysis inhibitor, which is shown to affect proteins involved in cellular metabolism and energy production. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor, impacting protein degradation pathways. If 1700063H04Rik is regulated through proteasomal degradation, Bortezomib is shown to influence its levels or activity. | ||||||